1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
High Oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer
(
- Contribution to journal › Article
- 2022
-
Mark
High PGD2 receptor 2 levels are associated with poor prognosis in colorectal cancer patients and induce VEGF expression in colon cancer cells and migration in a zebrafish xenograft model
(
- Contribution to journal › Article
-
Mark
Combined Estrogen Alpha and Beta Receptor Expression Has a Prognostic Significance for Colorectal Cancer Patients
(
- Contribution to journal › Article
- 2021
-
Mark
Brain-derived neurotrophic factor, neutrophils and cysteinyl leukotriene receptor 1 as potential prognostic biomarkers for patients with colon cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Tumour-suppressive effect of oestrogen receptor β in colorectal cancer patients, colon cancer cells, and a zebrafish model
(
- Contribution to journal › Article
-
Mark
Tumour suppressor 15-hydroxyprostaglandin dehydrogenase induces differentiation in colon cancer via GLI1 inhibition
(
- Contribution to journal › Article
- 2019
-
Mark
High expression of estrogen receptor beta correlates with anti-tumorigenic and anti-proliferative inflammatory proteins in colorectal cancer patients
(
- Contribution to journal › Article
-
Mark
To investigate the role of PGD2 and its receptor signalling in colon cancer pathophysiology
(
- Contribution to journal › Article
- 2017
-
Mark
M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases
(
- Contribution to journal › Article
-
Mark
Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer
(
- Contribution to journal › Article